Puma Biotechnology announces presentation of findings from a phase II study of alisertib in… BusinessWire Jun 3, 2024 Ongoing biomarker analysis may help clarify which patients could benefit most from alisertib Puma Biotechnology, announced the…
Frost & Sullivan releases drug launch and Phase III trial watch list for top therapeutic areas Usha Sharma Jan 20, 2015 Oncology, autoimmune and infectious diseases/vaccines are areas for novel therapeutics and in vitro diagnostics in 2015
